C21ORF91 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.377760E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.626600E-01
Normal-vs-Stage2
1.899510E-03
Normal-vs-Stage3
1.554600E-01
Normal-vs-Stage4
1.427160E-01
Stage1-vs-Stage2
2.028600E-01
Stage1-vs-Stage3
1.795590E-01
Stage1-vs-Stage4
6.726200E-01
Stage2-vs-Stage3
1.503650E-02
Stage2-vs-Stage4
7.071400E-01
Stage3-vs-Stage4
2.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.419580E-03
Normal-vs-AfricanAmerican
1.345410E-01
Normal-vs-Asian
1.513440E-01
Caucasian-vs-AfricanAmerican
4.508000E-01
Caucasian-vs-Asian
1.654230E-01
AfricanAmerican-vs-Asian
9.842400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.316500E-03
Normal-vs-Female
3.297600E-03
Male-vs-Female
1.824390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.131000E-01
Normal-vs-Age(41-60Yrs)
1.092220E-02
Normal-vs-Age(61-80Yrs)
1.035260E-03
Normal-vs-Age(81-100Yrs)
1.774250E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.715600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.716000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.735800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.837800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.594570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.827150E-01
Normal-vs-Daily Drinker
1.444760E-01
Normal-vs-Weekly Drinker
1.823980E-01
Normal-vs-Occasional Drinker
1.829030E-01
Normal-vs-Social Drinker
1.814630E-01
Non Drinker-vs-Daily Drinker
1.202250E-01
Non Drinker-vs-Weekly Drinker
9.729000E-01
Non Drinker-vs-Occasional Drinker
9.630400E-01
Non Drinker-vs-Social Drinker
1.776750E-01
Daily Drinker-vs-Weekly Drinker
1.474220E-01
Daily Drinker-vs-Occasional Drinker
1.672400E-01
Daily Drinker-vs-Social Drinker
4.296100E-02
Weekly Drinker-vs-Occasional Drinker
9.914000E-01
Weekly Drinker-vs-Social Drinker
1.775970E-01
Occasional Drinker-vs-Social Drinker
1.818380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.258000E-01
Normal-vs-Grade 2
1.149400E-01
Normal-vs-Grade 3
7.661900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.678400E-01
Grade 1-vs-Grade 3
2.121200E-01
Grade 1-vs-Grade 4
3.258000E-01
Grade 2-vs-Grade 3
7.254400E-01
Grade 2-vs-Grade 4
1.149400E-01
Grade 3-vs-Grade 4
7.661900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.155200E-03
Normal-vs-NonDiabetic
3.158400E-04
Diabetic-vs-NonDiabetic
5.178600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.589790E-01
Normal-vs-NoPancreatitis
7.550600E-04
Pancreatitis-vs-NoPancreatitis
3.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.796100E-03
Normal-vs-N1
1.436180E-03
N0-vs-N1
5.424200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.428620E-01
Normal-vs-TP53-NonMutant
2.659800E-02
TP53-Mutant-vs-TP53-NonMutant
6.276200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
